Minnesota Cancer Plan 2025 Objective 10 Clinical Trials Youtube The minnesota cancer clinical trials network (mncctn) aims to improve cancer outcomes for all minnesotans through greater access to cancer clinical trials in prevention and treatment. the minnesota cancer clinical trials network: bringing clinical trials to you . Nearly half of all minnesotans will be diagnosed with a potentially life threatening cancer during their lifetime; but 56 percent of minnesotans have fewer options for treatment because they live more than 30 miles from a hospital or clinic that offers access to clinical trials. thanks to a new state funded partnership between the university of minnesota […].
Minnesota Cancer Clinical Trials Network Opens Next Grant Program Cycl The minnesota cancer clinical trials network (mncctn) aims to improve cancer outcomes for all minnesotans through greater access to cancer clinical trials in. The network, funded by the minnesota legislature, has opened several studies in the past year, including trials involving preventing cancer and improving the quality of life of cancer patients undergoing chemotherapy. the network’s newest trial, a study examining exemestane as a therapy for postmenopausal women with non small cell lung cancer. By bringing cancer clinical trials directly to those living in greater minnesota, mncctn breaks down barriers like: distance. prior to mncctn, cancer clinical trials were available in limited locations. time. traveling to these few locations required significant time away from work and family. costs. traveling incurs many indirect costs to. Today, access to clinical cancer trials is difficult for many minnesotans; 56 percent of state residents live more than 30 miles from a hospital or clinic that offers access to such trials. by bringing cancer clinical trials to those living in greater minnesota, the mncctn will increase access to potentially lifesaving and life changing.
Minnesota Cancer Clinical Trials Network Funds Colorectal Cancer By bringing cancer clinical trials directly to those living in greater minnesota, mncctn breaks down barriers like: distance. prior to mncctn, cancer clinical trials were available in limited locations. time. traveling to these few locations required significant time away from work and family. costs. traveling incurs many indirect costs to. Today, access to clinical cancer trials is difficult for many minnesotans; 56 percent of state residents live more than 30 miles from a hospital or clinic that offers access to such trials. by bringing cancer clinical trials to those living in greater minnesota, the mncctn will increase access to potentially lifesaving and life changing. The clinical trials strategy action group are minnesota cancer alliance (mca) members and their partners who have interest or expertise in cancer clinical trials and are working towards objective 10 of the minnesota cancer plan 2025 to increase participation in cancer treatment clinical trials. 7 research bases develop and coordinate clinical trials and cancer care research for 32 community sites and 14 minority underserved community sites to bring nci approved trials to patients including 1,000 locations at diverse, community based hospitals, private practices and more.
Comments are closed.